| Literature DB >> 27035414 |
Cheng Chen1,2,3, Qi Zhao1,3, Yi Hu1,3, Yan Shao2, Guoli Li2, Limei Zhu2, Wei Lu2, Biao Xu1,3,4.
Abstract
Genome-wide association studies (GWASs) have yet to be conducted for tuberculosis (TB) susceptibility in China. Two previously identified single nucleotide polymorphisms (SNPs) from tuberculosis GWASs, rs2057178 and rs4331426, were evaluated for TB predisposition. The associations between SNPs and gene expression levels were analyzed using the genomic data and corresponding whole-genome expression of the Han Chinese in Beijing, China. Genotyping was successfully completed for 763 pulmonary TB patients and 763 healthy controls. The T allele of the rare variant rs2057178 was significantly associated with TB predisposition (χ(2) = 14.07, P = 0.0002). Meanwhile, the CT genotype of rs2057178 was associated with a decreased risk of TB (adjusted OR = 0.52, 95% CI, 0.34-0.78). The CT genotype of rs2057178 was also associated with decreased expression levels of infection-related gene, suppressor of cytokine signaling 2 (SOCS2), and increased expression levels of v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B (MAFB). No gene expression levels were found to be associated with the genotype of rs4331426. We found that the rare variant rs2057178 was significantly associated with TB in the Han Chinese population. Moreover, the expression levels of MAFB and SOCS2 correlated with rs2057178 and might be potential candidates for assessing TB susceptibility.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27035414 PMCID: PMC4817510 DOI: 10.1038/srep24016
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The genotypes distribution of rs2057178 and rs4331426 between tuberculosis cases and controls.
| Genotypes | Controls (N = 763) n(%) | Cases (N = 763) n(%) | Crude ORs and 95% CI | Adjusted ORs and 95% CI |
|---|---|---|---|---|
| rs2057178 | ||||
| CC | 692 (90.7%) | 724 (94.9%) | 1.00 | 1.00 |
| CT | 67 (8.8%) | 37 (4.8%) | 0.53 (0.35–0.80) | 0.52 (0.34–0.78) |
| TT | 4 (0.5%) | 2 (0.3%) | 0.48 (0.09–2.62) | 0.56 (0.10–3.10) |
| Dominant model CT + TT vs. CC | 71 (9.4%) | 39 (5.1%) | 0.53 (0.35–0.79) | 0.52 (0.35–0.78) |
| T allele frequency | 0.048 | 0.027 | χ2 = 14.07, | |
| Hardy-Weinberg equilibrium | χ2 = 2.79, | |||
| rs4331426 | ||||
| AA | 718 (94.1%) | 715 (93.7%) | 1.00 | 1.00 |
| AG | 44 (5.8%) | 48 (6.3%) | 1.10 (0.72–1.67) | 1.08 (0.71–1.66) |
| GG | 1 (0.1%) | 0 | NA | NA |
| Dominant model AG + GG vs. AA | 45 (5.9%) | 48 (6.3%) | 1.07 (0.70–1.63) | 1.06 (0.70–1.62) |
| G allele frequency | 0.030 | 0.031 | χ2 = 0.04, | |
| Hardy-Weinberg equilibrium | χ2 = 0.142, | |||
*Adjusted by age and gender.
The genotypes distribution of rs2057178 and rs4331426 between tuberculosis cases and IGRA positive and negative controls.
| Genotypes | Cases (N = 763) n(%) | QTF Negative Controls (N = 587) n(%) | Crude ORs and 95% CI | Adjusted ORs and 95% CI | QTF Positive Controls (N = 176) n(%) | Crude ORs and 95% CI | Adjusted ORs and 95% CI | |
|---|---|---|---|---|---|---|---|---|
| rs2057178 | ||||||||
| CC | 724 (94.9%) | 537 (91.5%) | 1.00 | 1.00 | 155 (88.1%) | 1.00 | 1.00 | |
| CT | 37 (4.8%) | 47 (8.0%) | 0.58 (0.37–0.91) | 0.57 (0.36–0.90) | 20 (11.4%) | 0.40 (0.22–0.70) | 0.40 (0.23–0.72) | 0.0006 |
| TT | 2 (0.3%) | 3 (0.5%) | 0.49 (0.08–2.97) | 0.62 (0.10–3.74) | 1 (0.6%) | 0.43 (0.04–4.75) | 0.30 (0.03–3.46) | |
| Dominant model CT + TT vs. CC | 39 (5.1%) | 50 (8.5%) | 0.58 (0.38–0.89) | 0.57 (0.37–0.89) | 21 (12.0%) | 0.40 (0.23–0.70) | 0.40 (0.23–0.70) | |
| rs4331426 | ||||||||
| AA | 715 (93.7%) | 547 (93.2%) | 1.00 | 1.00 | 171 (97.2%) | 1.00 | 1.00 | |
| AG | 48 (6.3%) | 39 (6.6%) | 0.94 (0.61–1.46) | 0.93 (0.60–1.44) | 5 (2.8%) | 2.30 (0.90–5.85) | 2.33 (0.91–5.96) | 0.2327 |
| GG | 0 | 1 (0.2%) | NA | NA | 0 | NA | NA | |
| Dominant model AG + GG vs. AA | 48 (6.3%) | 40 (6.8%) | 0.92 (0.60–1.42) | 0.90 (0.58–1.40) | 5 (2.8%) | 2.30 (0.90–5.85) | 2.33 (0.91–5.96) | |
*Adjusted by age and gender.
The genotypes of rs2057178 in association with specific gene expressions.
| ID | Adjusted P for moderate | Adjusted P for usual | Fold Change | Gene.title | Gene.symbol |
|---|---|---|---|---|---|
| GI_31377766-S | 0.058 | 0.087571289 | 0.5 | polymerase (RNA) II (DNA directed) polypeptide M | POLR2M |
| GI_33667071-S | 0.063 | 0.09215385 | 0.50698 | CD300a molecule | CD300A |
| GI_12545379-S | 0.063 | 0.09215385 | 1.580083 | secretin | SCT |
| GI_7705930-S | 0.09 | 0.098064729 | 0.378929 | HECT and RLD domain containing E3 ubiquitin protein ligase 5 | HERC5 |
| GI_27312030-S | 0.09 | 0.098064729 | 1.164734 | tumor suppressor candidate 5 | TUSC5 |
| GI_27545446-S | 0.09 | 0.112547153 | 0.547147 | vesicle-associated membrane protein 7 | VAMP7 |
| GI_29789067-S | 0.127 | 0.156789692 | 1.42405 | family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 | FAM19A5 |
| GI_24497598-A | 0.131 | 0.162399477 | 0.673617 | phosphatidylinositol glycan anchor biosynthesis, class P | PIGP |
| GI_42542393-S | 0.131 | 0.165706023 | 0.68302 | lysophosphatidylcholine acyltransferase 3 | LPCAT3 |
| GI_18491001-S | 0.131 | 0.162399477 | 0.888843 | WNT1 inducible signaling pathway protein 2 | WISP2 |
| GI_4885286-S | 0.131 | 0.165706023 | 0.702222 | guanine nucleotide binding protein (G protein), gamma 5 | GNG5 |
| GI_24307950-S | 0.131 | 0.165706023 | 0.582367 | tudor domain containing 7 | TDRD7 |
| GI_4758669-S | 0.131 | 0.165706023 | 0.594604 | leupaxin | LPXN |
| GI_31652256-S | 0.131 | 0.165706023 | 1.310393 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B | MAFB |
| GI_19924155-A | 0.14 | 0.173671278 | 0.752623 | regulatory factor X-associated ankyrin-containing protein | RFXANK |
| GI_27734778-S | 0.149 | 0.191442937 | 0.823591 | DTW domain containing 2 | DTWD2 |
| GI_21536304-S | 0.149 | 0.194057035 | 0.426317 | suppressor of cytokine signaling 2 | SOCS2 |
| GI_40353206-S | 0.149 | 0.194057035 | 0.554785 | MRG/MORF4L binding protein | MRGBP |
| GI_6912277-S | 0.149 | 0.194057035 | 0.641713 | COMM domain containing 3 | COMMD3 |
| GI_4757769-S | 0.149 | 0.194057035 | 0.607097 | ras homolog family member H | RHOH |
| GI_7019372-S | 0.149 | 0.200727205 | 0.528509 | fasciculation and elongation protein zeta 2 (zygin II) | FEZ2 |
| GI_22212923-I | 0.177 | 0.220792973 | 0.773782 | nuclear transcription factor, X-box binding 1 | NFX1 |
| GI_8922698-S | 0.177 | 0.220792973 | 0.574349 | CNDP dipeptidase 2 (metallopeptidase M20 family) | CNDP2 |
| GI_37059763-S | 0.177 | 0.220792973 | 0.550953 | gephyrin | GPHN |
| GI_38683857-I | 0.185 | 0.220792973 | 0.864537 | interferon regulatory factor 5 | IRF5 |
| GI_34222319-S | 0.185 | 0.235007739 | 0.524858 | Josephin domain containing 1 | JOSD1 |
| GI_42794768-S | 0.198 | 0.235007739 | 0.550953 | p21 protein (Cdc42/Rac)-activated kinase 1 | PAK1 |
| GI_23397652-S | 0.199 | 0.235007739 | 0.668964 | phosphatidylinositol glycan anchor biosynthesis, class T | PIGT |
*Adjusted by Benjamini & Hochberg.
Figure 1MAFB mRNA expression levels among the different genotypes of rs2057178 of the CHB.
Figure 2SOCS2 mRNA expression levels among the different genotypes of rs2057178 of the CHB.
Figure 3IRF5 mRNA expression levels among the different genotypes of rs2057178 of the CHB.